Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

70.09%

64.90%

61.75%

66.15%

Annual Dental Visits (ADV) Total

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

49.97%

46.74%

43.60%

48.16%

Appropriate Testing for Pharyngitis (CWP)

35.00%

77.56%

43.19%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

93.09%

93.08%

89.16%

91.27%

Asthma Medication Ratio (AMR) Total

61.84%

69.41%

58.68%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

54.12%

66.19%

53.76%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

63.26%

68.61%

67.88%

71.78%

Breast Cancer Screening (BCS)

51.83%

55.25%

Breast Cancer Screening (BCS-E)

51.72%

54.94%

51.75%

56.66%

Cervical Cancer Screening (CCS)

51.09%

59.85%

50.36%

60.10%

Childhood Immunization Status (CIS) Combination #10

33.33%

35.04%

26.28%

31.32%

Chlamydia Screening in Women (CHL) Total

61.48%

61.07%

65.28%

61.46%

Controlling High Blood Pressure (CBP)

58.64%

65.45%

67.88%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

80.53%

80.86%

86.42%

83.51%

Eye Exam for Patients With Diabetes (EED)

53.04%

56.20%

54.01%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

17.85%

27.73%

19.99%

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

28.36%

46.35%

17.07%

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

16.94%

41.03%

3.82%

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

16.67%

37.31%

8.08%

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

46.26%

57.90%

44.44%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

44.44%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

56.45%

55.72%

55.23%

59.64%

Immunizations for Adolescents (IMA) Combination #2

32.91%

38.93%

34.31%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

8.46%

16.94%

7.13%

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

48.18%

38.80%

49.91%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

40.79%

39.01%

42.63%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

42.63%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

21.51%

31.93%

10.48%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

65.61%

75.79%

60.29%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

86.07%

86.96%

82.90%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

86.88%

≤ 92.72%

89.48%

≤91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

84.18%

86.86%

82.48%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

82.00%

80.78%

79.56%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

22.97%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

22.97%

25.81%

24.36%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

2.74%

≤ 2.45%

2.65%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

55.46%

81.64%

79.69%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

83.88%

73.63%

70.23%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

69.49%

67.07%

68.26%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

82.00%

70.37%

66.41%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

29.46%

63.89%

57.81%

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

73.36%

75.44%

70.42%

72.74%

Use of Opioids at High Dosage (HDO)

2.09%

≤ 2.19%

1.75%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

0.17%

≤ 0.87%

0.78%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

82.97%

83.21%

87.35%

86.20%